TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD))

NCT06169722 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

GVHD, Chronic

Interventions

DRUG: TDI01 suspension

Sponsor

Beijing Tide Pharmaceutical Co., Ltd